Evening of 10th April 2018
Theranexus Conference & Cocktail
Meet the management of Theranexus, an innovative biopharmaceutical company in the treatment of neurological diseases and a pioneer in the design and development of drug candidates that play on the interaction between neurons and glial cells.
Built on a unique and patented technology, the Theranexus platform enables the generation of drug candidates with reduced development time and significantly increased market access opportunities. Its most advanced product is already in Phase 2, and is set to become the gold standard treatment for narcolepsy and excessive sleepiness in Parkinson’s disease